Zenas BioPharma is a biopharmaceutical company that is striving to develop and commercialize inflammatory and immunology therapies. The company aims to address the unmet needs of patients who experience autoimmune and rare diseases by discovering differentiated approaches to current treatments. Zenas BioPharma was founded in 2019 and is headquartered in Waltham, MA. The company's lead product candidate is obexelimab, which is a bifunctional monoclonal antibody that was designed to inhibit B-cell activity.

Register for Details

For more details on financing and valuation for Zenas BioPharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Zenas BioPharma

Forge green plus iconForge green minus icon

What is Zenas BioPharma's IPO price?

The IPO price for Zenas BioPharma will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Zenas BioPharma?

Zenas BioPharma is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Zenas BioPharma shares pre-IPO?

If you own Zenas BioPharma pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Zenas BioPharma a publicly traded company?

Zenas BioPharma is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Zenas BioPharma founded?

Zenas BioPharma was founded in 2020.

Who are Zenas BioPharma's major investors?

New Enterprise Associates
Norwest Venture Partners
Wellington Management
Bristol Myers Squibb
Longitude Capital
Perceptive Advisors
Rock Springs Capital
Vivo Capital
Delos Capital
ArrowMark Partners
Agent Capital
Pivotal bioVenture Partners
SR One Capital Management
Pivotal Life Sciences
Enavate Sciences
Federated Hermes
Lepu Biopharma
Quantum Ventures
Fairmount Funds Management
Quan Capital
Superstring Capital Management
Tellus BioVentures
Wuxi Biologics
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.